Dow Up0.09% Nasdaq Down0.02%

Allergan Inc. (AGN)

-NYSE
162.76 Down 1.21(0.74%) Aug 27, 4:01PM EDT
|After Hours : 162.76 0.00 (0.00%) Aug 27, 6:44PM EDT
ProfileGet Profile for:
Allergan Inc.
2525 Dupont Drive
Irvine, CA 92612
United States - Map
Phone: 714-246-4500
Fax: 714-246-6987
Website: http://www.allergan.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Drug Manufacturers - Other
Full Time Employees:11,700

Business Summary 

Allergan, Inc. operates as a multi-specialty health care company primarily in the United States, Europe, Latin America, and the Asia Pacific. The company discovers, develops, and commercializes pharmaceutical, biological, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological, and other specialty markets. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment produces a range of pharmaceutical products, including ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy, and retinal disease; Botox for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth, and other prescription and physician-dispensed skin care products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery, as well as tissue expanders; and facial aesthetics products. The company also holds LiRIS Program, which is in Phase II trials for the treatment of interstitial cystitis/bladder pain syndrome. It sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, ambulatory surgery centers, government purchasing agencies, and medical practitioners. The company focuses on eye care professionals, neurologists, physiatrists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, urologists, urogynecologists, and general practitioners. It has collaboration agreements with Molecular Partners AG; Spectrum Pharmaceuticals, Inc.; and Serenity Pharmaceuticals, LLC. Allergan, Inc. was founded in 1948 and is headquartered in Irvine, California.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Allergan Inc.

Corporate Governance 
Allergan Inc.’s ISS Governance QuickScore as of Aug 1, 2014 is 8. The pillar scores are Audit: 1; Board: 10; Shareholder Rights: 9; Compensation: 3.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. David E. I. Pyott , 60
Chairman and Chief Exec. Officer
3.24M0.00
Mr. Douglas S. Ingram J.D., Esq., 51
Pres
1.91M0.00
Dr. Scott M. Whitcup M.D., 55
Chief Scientific Officer and Exec. VP of R&D
1.16M7.62M
Mr. Julian S. Gangolli , 56
Corp. VP and Pres of North America
933.00K2.96M
Mr. Jeffrey L. Edwards , 53
Non-Exec. Officer
1.16M6.86M
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders